Innometry Balance Sheet Health
Financial Health criteria checks 5/6
Innometry has a total shareholder equity of ₩70.4B and total debt of ₩510.3K, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩83.5B and ₩13.2B respectively. Innometry's EBIT is ₩7.3B making its interest coverage ratio -12.8. It has cash and short-term investments of ₩28.6B.
Key information
0.0007%
Debt to equity ratio
₩510.29k
Debt
| Interest coverage ratio | -12.8x |
| Cash | ₩28.65b |
| Equity | ₩70.36b |
| Total liabilities | ₩13.17b |
| Total assets | ₩83.53b |
Recent financial health updates
No updates
Recent updates
Innometry Co., Ltd. (KOSDAQ:302430) Stock Catapults 28% Though Its Price And Business Still Lag The Market
Sep 04
Innometry's (KOSDAQ:302430) Returns Have Hit A Wall
Aug 12There May Be Underlying Issues With The Quality Of Innometry's (KOSDAQ:302430) Earnings
Mar 27What Innometry Co., Ltd.'s (KOSDAQ:302430) 29% Share Price Gain Is Not Telling You
Mar 08The Innometry (KOSDAQ:302430) Share Price Has Gained 34% And Shareholders Are Hoping For More
Mar 10What Kind Of Investors Own Most Of Innometry Co., Ltd. (KOSDAQ:302430)?
Feb 19Innometry Co., Ltd. (KOSDAQ:302430) On An Uptrend: Could Fundamentals Be Driving The Stock?
Feb 04Tread With Caution Around Innometry Co., Ltd.'s (KOSDAQ:302430) 1.7% Dividend Yield
Jan 20Should You Be Impressed By Innometry's (KOSDAQ:302430) Returns on Capital?
Jan 01
Innometry's (KOSDAQ:302430) Earnings Are Growing But Is There More To The Story?
Dec 17Did Innometry's (KOSDAQ:302430) Share Price Deserve to Gain 38%?
Dec 02Financial Position Analysis
Short Term Liabilities: A302430's short term assets (₩62.3B) exceed its short term liabilities (₩13.0B).
Long Term Liabilities: A302430's short term assets (₩62.3B) exceed its long term liabilities (₩155.1M).
Debt to Equity History and Analysis
Debt Level: A302430 has more cash than its total debt.
Reducing Debt: A302430's debt to equity ratio has increased from 0% to 0% over the past 5 years.
Debt Coverage: A302430's debt is well covered by operating cash flow (2701363.2%).
Interest Coverage: A302430 earns more interest than it pays, so coverage of interest payments is not a concern.